Expectant and new mothers are expected to be happy; experiencing mental illness is taboo. Yet every tenth pregnant person, and just as many new mothers, have depressive symptoms.

“Our study shows how vital it is to detect depressive symptoms early in the pregnancy, and the need for standardised screening methods,” says Hafrún Finnbogadóttir, senior lecturer at Malmö University.

In Sweden, all mothers should be offered screening for depression when the newborn is 6-8 weeks old, the screening conducted through a self-evaluation survey. However, pregnant women are not screened for depression in Sweden and new mothers are only screened once.

So what is the health status of these women? Finnbogadóttir’s research shows that 6,2 per cent of the 1,939 pregnant women who took part in her study already had depressive symptoms at the initial meeting with a midwife. Throughout the whole pregnancy, about 10 per cent experienced depressive symptoms. The same percentage had these symptoms a year and a half post-delivery.

The research shows, with statistical significance, that women were likely not to be treated with antidepressant drugs. Among the women with depressive symptoms that also reported having been subjected to domestic violence, none were treated with antidepressant drugs. The lack of pharmaceutical treatment is an indication that these women go undetected and most likely don’t receive any treatment at all, Finnbogadóttir says.

“It is remarkable to both have such a young child and multiple depressive symptoms, as some of the women in the study had, and go undetected. The medical community ought to review routines and screen for symptoms of depression during pregnancy as well as other occasions during the child’s first years, for example at the one-year check-up at the BVC (child welfare centre). The health of the mother and the child is dependent on the mother’s mental wellbeing,” she says.

Finnbogadóttir notes that pharmaceutical treatment of pregnant women with depression is both complex and controversial, which is why further investigation is needed. There is concern that antidepressant drugs affect the foetus in negative ways. However, previous studies have shown that depression not only affects the mother’s own health negatively but also impairs their attachment to the child and makes the parent less sensitive to the child’s signals.

“It is serious to have apparent signs of depression and not receive treatment. Depressive symptoms reduce the mother’s ability to care for her child. Antidepressant drugs would alleviate their vulnerable situation.”

Finnbogadóttir wants to see improved cooperation between physicians within pregnancy and maternity care, midwives and psychiatry.

“Dialogue with the women is necessary. It is also important to look over routines and be more attentive to women with depressive symptoms early in the pregnancy. In many counties it is routine to screen pregnant women for depression. My international colleagues are surprised we don’t have this routine in Sweden.”

Text: Ellen Albertsdottir